Webinar:
MRDVision™: Powering therapeutic breakthroughs with 1 ppm level sensitivity
Dr. Erin Connolly-Strong, PhD | Chief Medical Officer
July 28, 2025 10:00 AM to 10:30 AM PT
In this webinar, you’ll learn…
- How our whole genome approach to MRD, powered by Ultima Genomics’ ppmSeq™ provides richer data and insights, and can unlock deeper understanding of the disease
- The benefits of a whole genome x whole genome approach to MRD, combined with unprecedented sensitivity and specificity
- Proven outcomes, including real-world evidence benchmarking WGS against today’s current standards
About the speaker:
Erin serves as the Chief Medical Officer at Inocras, overseeing medical affairs, clinical study design, and market access strategy. With a Ph.D. in Biomedical Science from Albert Einstein College of Medicine, Erin has held pivotal roles in pharmaceutical, biotech, and diagnostics companies, including notable positions at Scipher and Mallinckrodt.
She leads the development of clinical research to validate Inocras’ technology, utilizing her expertise to advance precision medicine. Erin is recognized for her leadership and commitment to enhancing patient outcomes.